Sai Shilpa Kommaraju - Public Profile
Refine search by
Public Profile

Sai Shilpa Kommaraju

[Available for Review]

H-index: 2

Manuscripts in Review: 4

Country: United States

Manuscript Review Cycle: 4 days 23 h

Total Points: 57

Institution: --

Keywords: Cancer, molecular biology, biochemistry, eukaryotic initiation factors, mechanism of action

Representative Publications

Synthesis of 2, 3-dihydrobenzo [b][1, 4] dioxine-5-carboxamide and 3-oxo-3, 4-dihydrobenzo [b][1, 4] oxazine-8-carboxamide derivatives as PARP1 inhibitors

Investigation of the mechanism of action of a potent pateamine A analog, des-methyl, des-amino pateamine A (DMDAPatA)

Second-generation derivatives of the eukaryotic translation initiation inhibitor pateamine A targeting eIF4A as potential anticancer agents

Reviewers you may be interested in

Chao Zhang

Total: 521

Country: Antarctica

H-index: 6

Verified Reviews: 55

Keywords: cancer, drug
Re Name

Total: 413

Country: United States

H-index: 16

Verified Reviews: 34

Keywords: cancer, drug
Xin Xie

Total: 97

Country: China

H-index: 12

Verified Reviews: 25

Keywords: Oncology, antibiotics, biochemistry, molecular biology, natural products, pharmacology, medicinal chemistry, structure-activity relationship, herbal, traditional medicine, alternative medicine
Vladimir Achikyan

Total: 96

Country: Russian Federation

H-index: --

Verified Reviews: 29

Keywords: Immunology, Rheumatology, inflammatory bowel disease, colitis, musculoskeletal disorders, pain, sleep disorders, HCV, liver disease, HIV, AIDS, Oncology, breast cancer, lung cancer, melanoma, Oncourology, clinical trials, clinical studies, real world data, real world evidence
xinna li

Total: 72

Country: United States

H-index: 10

Verified Reviews: 55

Keywords: I have strong research experience in molecular biology and biochemistry. In 2012, I joined the group of Richard Miller to study the mechanism of aging using longevity mouse models. My work has provided encouraging evidence that ARIs (Aging Rate Indicators) may be altered by genes, CR diet, and drugs in many tissues of many varieties of slow aging mice. The slow aging is attributed to a multitude of causes including mutations (Ames, Snell, GHR-KO, or PAPPA-KO) and CR diet, mice treated with rapamycin (Rapa), acarbose (Aca), 17aE2, and canagliflozin (Cana).These genes and interventions lead to many physiological changes such as 1) an increase in uncoupling protein UCP1 in brown and white adipose tissue (WAT); 2) a change in fat-associated macrophage subsets that leads to diminished production of inflammatory cytokines; 3) an increase in muscle fibronectin type III domain containing 5 (FNDC5) and its cleavage product, the myokine irisin, thought to cause changes in fat cell differentiation; 4) elevated production of hepatic GPLD1 and plasma GPLD1; 5) elevation of hippocampal BDNF and DCX, used as indices of neurogenesis.
José Roberto Ferreira

Total: 66

Country: Brazil

H-index: 13

Verified Reviews: 31

Keywords: Pharmacology, Apoptosis, Mechanism of Action, Drug discovery, Cancer, Metastasis

Feeling limited by your filters? Break free and rediscover!

All Reviewers